Safe First‑Line Antihypertensive Therapy in Pregnancy

First‑Line Medications

Labetalol, extended‑release nifedipine, and methyldopa are the only antihypertensive agents considered safe for use throughout all trimesters of pregnancy; all other classes (ACE inhibitors, ARBs, direct renin inhibitors, mineralocorticoid receptor antagonists) are absolutely contraindicated because of severe fetotoxicity. (European Heart Journal) 1
Labetalol is endorsed as a first‑line agent by the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. (European Heart Journal) 1
Extended‑release nifedipine is consistently recommended as first‑line therapy by multiple international cardiovascular guidelines. (European Heart Journal) 1
Methyldopa has the longest documented safety record in pregnancy, with child follow‑up data extending to 7.5 years. (European Heart Journal) 1
Labetalol is compatible with breastfeeding. (European Heart Journal) 1
Extended‑release nifedipine is compatible with breastfeeding. (European Heart Journal) 1
Methyldopa carries a less favorable side‑effect profile, notably an increased risk of postpartum depression, and therefore should be replaced by labetalol or nifedipine after delivery. (European Heart Journal) 1

Initiate antihypertensive therapy when systolic/diastolic BP reaches ≥ 140/90 mm Hg in gestational hypertension, pre‑existing hypertension with superimposed gestational hypertension, or hypertension with organ damage. (European Heart Journal) 1
For uncomplicated chronic hypertension, treatment may be started at ≥ 150/95 mm Hg. (European Heart Journal) 1
Target systolic blood pressure in pregnancy: 110–140 mm Hg. (European Heart Journal) 1
Target diastolic blood pressure in pregnancy: 85 mm Hg. (European Heart Journal) 1
If diastolic pressure falls below 80 mm Hg, antihypertensive agents should be reduced or discontinued to avoid compromising uteroplacental perfusion. (Praxis Medical Insights) 2
Severe hypertension (≥ 160/110 mm Hg persisting > 15 min) requires immediate treatment within 60 minutes. (European Heart Journal) 1

Oral immediate‑release nifedipine 10–20 mg (repeat every 20–30 min, max 30 mg in the first hour) or intravenous labetalol bolus 20 mg (escalating to 40 mg, then 80 mg every 10 min, max 300 mg) are recommended for rapid control of severe hypertension. (European Heart Journal) 1

ACE inhibitors (e.g., enalapril, lisinopril) are strictly contraindicated throughout pregnancy because of severe fetotoxicity, renal dysgenesis, and oligohydramnios. (European Heart Journal) 1
Angiotensin‑II receptor blockers (ARBs) are absolutely contraindicated in pregnancy. (Praxis Medical Insights) 3
Direct renin inhibitors are absolutely contraindicated in pregnancy. (Praxis Medical Insights) 3
Mineralocorticoid‑receptor antagonists are absolutely contraindicated in pregnancy. (Praxis Medical Insights) 3
Concurrent use of long‑acting nifedipine with intravenous magnesium sulfate is prohibited due to risk of precipitous hypotension, myocardial depression, and fetal compromise. (European Heart Journal) 1
Atenolol should be avoided because it is associated with a higher risk of fetal growth restriction. (Praxis Medical Insights) 2
Diuretics (e.g., hydrochlorothiazide, furosemide, spironolactone) are generally avoided owing to potential reduction in uteroplacental perfusion and suppression of lactation. (Praxis Medical Insights) 2
NSAIDs should not be used in women with pre‑eclampsia as they exacerbate hypertension and impair renal function. (Praxis Medical Insights) 2

Labetalol, extended‑release nifedipine, enalapril (unless the neonate is premature or has renal failure), and metoprolol are considered safe for use by breastfeeding mothers. (European Heart Journal for labetalol, nifedipine, enalapril; Praxis Medical Insights for metoprolol) [1][3]

Continue antihypertensive therapy immediately after delivery; abrupt discontinuation is discouraged because blood pressure often worsens during the first postpartum week. (Praxis Medical Insights) 2
Switch methyldopa to labetalol or nifedipine before hospital discharge to mitigate the risk of postpartum depression. (European Heart Journal) 1
Monitor blood pressure closely between days 3–6 postpartum, a period when hypertension frequently escalates. (Praxis Medical Insights) 2
If postpartum blood pressure reaches ≥ 160/110 mm Hg for > 15 min, treat urgently as per severe‑hypertension protocol. (Praxis Medical Insights) 2
Taper antihypertensive agents when diastolic pressure consistently falls below 80 mm Hg. (Praxis Medical Insights) 2
When combination therapy is required, taper labetalol first (due to multiple daily doses) and maintain extended‑release nifedipine (once‑daily dosing improves adherence). (Praxis Medical Insights) 2

Transition to pregnancy‑safe medications (labetalol, extended‑release nifedipine, or methyldopa) before attempting conception. (Praxis Medical Insights) 3
Discontinue ACE inhibitors, ARBs, and direct renin inhibitors prior to conception. (Praxis Medical Insights) 3
Start low‑dose aspirin (75–100 mg nightly) before 16 weeks gestation in women with additional risk factors for pre‑eclampsia. (European Heart Journal) 1
Consider calcium supplementation of ≥ 1 g daily to reduce the risk of pre‑eclampsia. (Praxis Medical Insights) 3